Fiche société
Ontario Neurodegeneration Disease Research Initiative
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications5liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| The Ontario Neurodegenerative Disease Research InitiativeDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. | Sclérose latérale amyotrophique | À vérifier | À vérifier | Canada | À vérifier |
| The Ontario Neurodegenerative Disease Research InitiativeDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. | Sclérose latérale amyotrophique | À vérifier | À vérifier | Canada | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| The Ontario Neurodegenerative Disease Research Initiative | Sclérose latérale amyotrophique | À vérifier | NCT04104373 | The Ontario Neurodegenerative Disease Research Initiative | COMPLETED |
Publications
5| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| The Ontario Neurodegenerative Disease Research Initiative | Ankle-worn accelerometers for gait analysis in people with Alzheimer's disease and mild cognitive impairment: reliability of a finite state machine approach. | Medical engineering & physics | ||
| The Ontario Neurodegenerative Disease Research Initiative | The ILLUMINATE natural history study in colony-stimulating factor 1 receptor-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. | Brain communications | ||
| The Ontario Neurodegenerative Disease Research Initiative | Educational attainment and sex modulate clinical outcomes in genetic frontotemporal dementia. | Brain communications | ||
| The Ontario Neurodegenerative Disease Research Initiative | A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism. | Nature medicine | ||
| The Ontario Neurodegenerative Disease Research Initiative | Application of a clinical scale for predicting Aβ-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment. | Journal of the neurological sciences |